Effects of hydrocortisone and aminophylline on the aggregation of equine platelets in vitro.

J Vet Sci

Department of Experimental Science and Applied Biotechnology, Laboratory of Chronophysiology, University of Messina, Messina 98168, Italy.

Published: September 2011

The purpose of this study was to evaluate in vitro the effects of hydrocortisone and aminophylline on adenosine diphosphate (ADP)-induced platelet aggregation in horses. Blood samples from 30 healthy Thoroughbred horses were collected by via jugular venipuncture to assess platelet aggregation. Platelet-rich and platelet-poor plasma were prepared from all samples by centrifugation and divided into three different aliquots. In the first aliquot, platelet aggregation was measured after platelet activation with 1 µM and 0.5 µM ADP (Group A). In the other two aliquots, the effect of a 10 min preincubation with hydrocortisone (Group B) or aminophylline (Group C) on ADP-induced aggregation at final ADP concentrations of 1 µM and 0.5 µM was observed. Platelet aggregation, recorded by an aggregometer, was evaluated by measuring the maximum degree of platelet aggregation and the initial velocities of platelet aggregation were obtained. Our results demonstrated the inhibitory effect of hydrocortisone and the induction effect of aminophylline on equine platelet responses in vitro.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165149PMC
http://dx.doi.org/10.4142/jvs.2011.12.3.215DOI Listing

Publication Analysis

Top Keywords

platelet aggregation
24
effects hydrocortisone
8
hydrocortisone aminophylline
8
aggregation
8
platelet
8
µm µm
8
aminophylline
4
aminophylline aggregation
4
aggregation equine
4
equine platelets
4

Similar Publications

Tirofiban hydrochloride is used to inhibit platelet aggregation, which has a significant impact on the treatment of congestive heart failure the most common cause of death according to WHO. Therefore, its quantification in pharmaceutical dosage form is critical. In this work, an electrochemical method for the determination of tirofiban HCl in pharmaceutical dosage form was developed and validated.

View Article and Find Full Text PDF

Decoding platelet loss in the hypoxic brain: What could go wrong?

J Physiol

January 2025

Cerebrovascular Health Exercise and Environmental Research Sciences Laboratory (CHEERS), Department of Exercise Science, Physical & Health Education, University of Victoria, Victoria, BC, Canada.

View Article and Find Full Text PDF

L. protects cerebral ischemia/reperfusion injury via arachidonic acid/p53-mediated apoptosis axis.

Front Pharmacol

December 2024

State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Introduction: Stroke is a debilitating disease and the second leading cause of death worldwide, of which ischemic stroke is the dominant type. L., also known as safflower, has been used to treat cerebrovascular diseases, especially ischemic stroke in many Asian countries.

View Article and Find Full Text PDF

Intracranial hemorrhages are highly concerning but underreported complications related to flow diversion (FD) treatment of intracranial aneurysms. Herein, we aimed to characterize these complications and the factors influencing their occurrence. We retrospectively reviewed patients treated with FD from 2013 to 2023 at a single U.

View Article and Find Full Text PDF

Background And Objectives: Despite achieving ideal reperfusion (eTICI = 3) through endovascular treatment (EVT), some acute ischemic stroke (AIS) patients still experience poor outcomes. This study aims to evaluate the efficacy and safety of tirofiban in AIS patients with ideal reperfusion, focusing on its effects in large artery atherosclerosis (LAA) and cardioembolic (CE) stroke.

Methods: A total of 474 AIS patients from the RESCUE-BT database were included.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!